With increased scrutiny of early stage investment for biotech start-ups linked to economics downturn from its peak in 2020-2021, targeted investor engagement is key for a successful financing round. Despite possessing highly derisked and innovative technology, data presentation must be refined in a highly digestable manner to attract interest from notable investors and potential strategic […]
Read More